Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients?

Mathilde Luce, Anais Bouchara, Myriam Pastural, Samuel Granjon, Jean Christophe Szelag, Maurice Laville, Walid Arkouche, Denis Fouque, Christophe O. Soulage, Laetitia Koppe

Open source

DOI
10.3390/toxins10050205
Published
2018-05-18
Container
Toxins
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/toxins10050205,
  title = {Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients?},
  author = {Mathilde Luce and Anais Bouchara and Myriam Pastural and Samuel Granjon and Jean Christophe Szelag and Maurice Laville and Walid Arkouche and Denis Fouque and Christophe O. Soulage and Laetitia Koppe},
  year = {2018},
  journal = {Toxins},
  doi = {10.3390/toxins10050205},
  url = {https://doi.org/10.3390/toxins10050205}
}

RIS

TY  - JOUR
TI  - Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients?
AU  - Mathilde Luce
AU  - Anais Bouchara
AU  - Myriam Pastural
AU  - Samuel Granjon
AU  - Jean Christophe Szelag
AU  - Maurice Laville
AU  - Walid Arkouche
AU  - Denis Fouque
AU  - Christophe O. Soulage
AU  - Laetitia Koppe
PY  - 2018
JO  - Toxins
DO  - 10.3390/toxins10050205
UR  - https://doi.org/10.3390/toxins10050205
ER  - 

APA

Luce, M., Bouchara, A., Pastural, M., Granjon, S., Szelag, J. C., Laville, M., Arkouche, W., Fouque, D., Soulage, C. O., & Koppe, L. (2018). Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients?. Toxins. https://doi.org/10.3390/toxins10050205

Source records